Date published: 2026-7-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

PRDM16 Double Nickase Plasmid (h): sc-403464-NIC

0.0(0)
Write a reviewAsk a question

Datasheets
  • Target species: human
  • 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
  • PRDM16 Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
  • Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
  • One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
  • PRDM16 Double Nickase Plasmid (h) and PRDM16 Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting PRDM16. One or both designs may be available
  • Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: PRDM16 Antibody (174A2D): sc-517625
    Gene Editing Promo Banner

    Ordering Information

    Product NameCatalog #UNITPriceQtyFAVORITES

    PRDM16 Double Nickase Plasmid (h)

    sc-403464-NIC
    20 µg
    $410.00

    PRDM16 Double Nickase Plasmid (h2)

    sc-403464-NIC-2
    20 µg
    $410.00

    PRDM16 encodes a PR/SET domain zinc-finger transcriptional regulator that integrates epigenetic control with lineage-specific gene expression programs. It is best known for coordinating adipocyte fate decisions, including brown and beige adipogenesis, through interactions with co-regulators and modulation of mitochondrial and oxidative metabolism gene networks. PRDM16 also contributes to developmental and stem/progenitor cell transcriptional states, influencing differentiation and tissue homeostasis. Dysregulated PRDM16 expression or rearrangement has been linked to altered metabolic phenotypes and oncogenic transcriptional programs in select hematologic contexts, making it relevant for pathway-focused mechanistic studies.

    PRDM16 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the PRDM16 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within PRDM16. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt PRDM16 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.

    To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of PRDM16-disrupted clones.

    For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.